Moderna Cash from Financing (Quarterly) Analysis

Moderna Inc (MRNA)

53.54 -1.09 (-2.00%) USD | NASDAQ | Nov 04, 16:00

53.54 0.00 (0.00%) Pre-Market: 08:42

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
June 30, 2024	34.00M
March 31, 2024	14.00M
December 31, 2023	-109.00M
September 30, 2023	-58.00M
June 30, 2023	-668.00M
March 31, 2023	-542.00M
December 31, 2022	-438.00M
September 30, 2022	-1.041B
June 30, 2022	-1.327B
March 31, 2022	-642.00M
December 31, 2021	-873.00M
September 30, 2021	-2.00M
June 30, 2021	-24.00M

Date	Value
March 31, 2021	26.00M
December 31, 2020	44.00M
September 30, 2020	30.00M
June 30, 2020	1.381B
March 31, 2020	578.00M
December 31, 2019	31.72M
September 30, 2019	15.81M
June 30, 2019	4.177M
March 31, 2019	0.293M
December 31, 2018	575.92M
September 30, 2018	-9.43M
June 30, 2018	110.36M
March 31, 2018	550.00M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-1.327B

Minimum

Jun 2022

1.381B

Maximum

Jun 2020

-188.70M

Average

-24.00M

Median

Jun 2021

Cash from Financing (Quarterly) Benchmarks

Eli Lilly and Co	211.30M
Merck & Co Inc	1.216B
Pfizer Inc	-2.459B
Novavax Inc	258.22M
Amgen Inc	-3.651B

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-1.274B
Cash from Investing (Quarterly)	1.649B
Free Cash Flow	-3.979B
Free Cash Flow Per Share (Quarterly)	-3.792
Free Cash Flow to Equity (Quarterly)	-1.456B
Free Cash Flow to Firm (Quarterly)	-1.456B
Free Cash Flow Yield	-19.44%